LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 62 filers reported holding LEGEND BIOTECH CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,783,763 | +96496.1% | 244,375 | 0.0% | 0.82% | -41.8% |
| Q4 2022 | $12,199 | -99.9% | 244,375 | 0.0% | 1.40% | +27.6% |
| Q3 2022 | $9,971,000 | -25.8% | 244,375 | 0.0% | 1.10% | -18.4% |
| Q2 2022 | $13,441,000 | +51.3% | 244,375 | 0.0% | 1.35% | +120.6% |
| Q1 2022 | $8,881,000 | -22.0% | 244,375 | 0.0% | 0.61% | -10.9% |
| Q4 2021 | $11,390,000 | -53.9% | 244,375 | -50.0% | 0.69% | -38.1% |
| Q3 2021 | $24,711,000 | -37.1% | 488,751 | -48.9% | 1.11% | -34.7% |
| Q2 2021 | $39,273,000 | -50.9% | 956,702 | -65.3% | 1.70% | -39.5% |
| Q1 2021 | $79,950,000 | +3.1% | 2,755,007 | 0.0% | 2.81% | -18.8% |
| Q4 2020 | $77,581,000 | -24.5% | 2,755,007 | -17.3% | 3.46% | -41.7% |
| Q3 2020 | $102,805,000 | -32.1% | 3,330,269 | -6.3% | 5.94% | -45.2% |
| Q2 2020 | $151,301,000 | – | 3,555,007 | – | 10.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |